Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Blood Cancer Research Partnership's (BCRP) mission is to provide innovative clinical trials to patients closer to their home. Far too often, patients diagnosed with cancer do not have access to ground-breaking trials due to lack of proximity to large
BCRP's main objective is to bring the novel trials to the patients across the country. We believe the collaboration between community oncologists and Dana-Farber Cancer Institute physicians will accelerate the advancement of and expansion of access to
well-designed and innovative clinical trials for blood cancer patients being treated at community sites.